Open AccessNeutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer
Author(s) -
Kwangmin Kim,
Hyang Suk Choi,
Han-Jin Noh,
InJeong Cho,
Seung Taek Lim,
Jong-In Lee,
Airi Han
Publication year - 2021
Publication title -
journal of breast cancer/journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 36
eISSN - 2092-9900
pISSN - 1738-6756
DOI - 10.4048/jbc.2021.24.e43
Subject(s) - medicine , breast cancer , oncology , triple negative breast cancer , neutrophil to lymphocyte ratio , survival analysis , cancer , lymphocyte , overall survival , retrospective cohort study , clinical trial
Triple-negative breast cancer (TNBC) has been associated with worse prognosis, and biomarkers are needed to identify high-risk patients who may benefit from clinical trials or escalated treatment after completion of standard treatment. We aimed to assess whether the post-treatment neutrophil-to-lymphocyte ratio (NLR) can reflect patient prognosis and determine the follow-up period that can provide the most feasible data.